The gut microbiome is closely connected with metabolism.
This article is part of the AKK Knowledge Centre, our guide hub for metabolic wellness, gut health and Akkermansia research.
Gut microorganisms can influence the chemical environment of the intestine and produce molecules that enter communication networks involving:
- the intestinal barrier,
- liver,
- immune system,
- adipose tissue,
- skeletal muscle,
- nervous system.
This has led to major interest in whether the microbiome contributes to:
- insulin resistance,
- obesity,
- blood glucose regulation,
- metabolic syndrome,
- fatty liver disease.
The answer is likely yes — but not in the simple way often presented online.
There is no single “metabolic microbiome,” and no single bacterial species can determine whether someone is metabolically healthy.
Key Takeaways
- Gut microbes produce metabolites that can influence host metabolism.
- Short-chain fatty acids, bile-acid metabolites and amino-acid metabolites are active areas of research.
- People with metabolic disorders often have different microbiome patterns from comparison groups.
- Association does not prove causation.
- Diet, medication and body weight can change the microbiome and metabolic markers at the same time.
- Akkermansia is one important research organism, but higher Akkermansia is not automatically better.
- Microbiome-targeted metabolic interventions remain an emerging field.
- Lifestyle fundamentals should not be replaced by attempts to manipulate one bacterium.
How Can Gut Microbes Affect Metabolism?
Microorganisms interact with food and host-derived compounds.
They can transform:
- dietary fibre,
- resistant starch,
- polyphenols,
- bile acids,
- amino acids,
- mucus.
This produces thousands of microbial metabolites.
Some remain inside the gut.
Others are absorbed and can interact with distant organs.
Short-Chain Fatty Acids
SCFAs include:
- acetate,
- propionate,
- butyrate.
They are produced largely from microbial fermentation of carbohydrates.
SCFAs can interact with:
- intestinal epithelial cells,
- immune pathways,
- liver metabolism,
- endocrine signalling.
But their effects depend on location and concentration.
Higher stool SCFAs are not automatically better.
Bile Acids
The liver produces primary bile acids.
Gut microorganisms can transform them into secondary bile acids and other derivatives.
These compounds can interact with receptors involved in:
- glucose metabolism,
- lipid metabolism,
- energy expenditure.
This creates a direct link between gut microbial activity and host metabolic signalling.
Amino-Acid Metabolites
Microbes also transform amino acids.
Some microbial products are being studied for potentially beneficial effects.
Others may be associated with metabolic risk.
A 2025 Nature Reviews Endocrinology research highlight described work linking certain aromatic-amino-acid-derived microbial metabolites with adiposity in a human cohort, followed by mechanistic studies in mice.
This is a good example of how the field works:
- find an association in humans,
- test possible mechanisms,
- then determine whether the pathway is clinically useful.
Is the Microbiome Different in Obesity?
Many studies report differences in microbial composition between people with obesity and lean comparison groups.
But there is no universal obesity microbiome.
Results vary across:
- populations,
- countries,
- diets,
- medication,
- sequencing methods.
Early ideas that one simple ratio of bacterial phyla could explain obesity have not held up as a universal biomarker.
Is the Microbiome Different in Insulin Resistance?
Yes, associations have been reported.
But insulin resistance itself can affect:
- diet,
- medication,
- body weight,
- intestinal physiology.
This makes cause and effect difficult to separate.
Microbiome studies need careful adjustment for these confounders.
What About Metformin?
Metformin is a classic example of why medication matters.
People taking metformin can show major microbiome differences.
Some studies report increased abundance of Akkermansia muciniphila and other organisms.
If researchers compare people with and without type 2 diabetes without accounting for medication, they may incorrectly attribute a drug effect to the disease.
What Is Akkermansia?
Akkermansia muciniphila is a mucus-associated gut bacterium.
It has become a major candidate in next-generation microbiome research because observational and experimental studies link it with aspects of metabolic biology.
Human trials now exist for specific live and pasteurised preparations.
But it is essential to distinguish:
- association,
- mechanistic evidence,
- product-specific clinical evidence.
A study on one Akkermansia strain does not prove that every AKK supplement improves metabolic health.
Does More Akkermansia Mean Better Metabolism?
No.
Akkermansia abundance varies between people.
Different strains can behave differently.
Its effects can depend on:
- diet,
- mucus environment,
- other microbes,
- host genetics,
- metabolic status.
The useful question is not:
“How do I maximise Akkermansia?”
It is:
“What role does Akkermansia play in this microbial ecosystem and what evidence supports a specific intervention?”
Can Diet Change the Metabolic Microbiome?
Yes.
Diet is one of the strongest modifiable influences on microbial function.
Diet changes:
- fermentable substrates,
- polyphenols,
- fat composition,
- protein substrates,
- microbial metabolites.
A diet can therefore affect metabolic health directly and through microbiome-mediated pathways.
These mechanisms occur together.
Do Probiotics Improve Metabolic Health?
Some specific probiotic strains and combinations have been studied for metabolic outcomes.
Meta-analyses sometimes show modest changes in:
- glucose,
- lipids,
- inflammatory markers.
But effects are inconsistent and strain-specific.
“Probiotic” is too broad a category to make one universal metabolic claim.
What About Prebiotics?
Prebiotics can selectively influence gut microorganisms.
Some interventions improve:
- bowel function,
- microbial composition,
- certain metabolic markers.
But responses vary substantially by baseline microbiome.
What About Postbiotics?
Postbiotics are defined preparations of inactivated microorganisms or their components with demonstrated health benefit.
They may offer a way to use microbial biology without requiring living organisms.
Pasteurised Akkermansia is one example under active study, but terminology and evidence must remain preparation-specific.
Can Microbiome Tests Predict Metabolic Risk?
Not reliably enough to replace standard screening.
Established clinical measurements such as:
- fasting glucose,
- HbA1c,
- blood pressure,
- lipids,
- waist circumference
are much more clinically actionable.
A consumer stool test may provide interesting information but should not be treated as a substitute.
Can the Microbiome Cause Weight Loss?
No microbiome intervention should be described this simply.
Body weight depends on:
- energy intake,
- energy expenditure,
- physiology,
- medication,
- genetics,
- environment.
The microbiome may influence some of these systems, but it is one part of the network.
Frequently Asked Questions
Is there a gut bacterium that controls metabolism?
No single bacterial species controls metabolism.
Is Akkermansia good for metabolic health?
Specific Akkermansia preparations are being studied in human clinical trials. Evidence should not be generalised to every product or every person.
Can probiotics reduce insulin resistance?
Some studies report modest effects for specific probiotics, but there is no universal probiotic treatment for insulin resistance.
Can gut bacteria affect body weight?
The microbiome can influence energy and metabolic pathways, but body weight is multifactorial.
Should I get a microbiome test for metabolic health?
Not instead of standard clinical screening.
The Bottom Line
The gut microbiome is genuinely connected with metabolic health.
But the science is about networks, not one “skinny bacterium.”
Microbial metabolites, diet, medication, the intestinal barrier and host physiology interact continuously.
The strongest current strategy is therefore:
- support overall diet quality,
- maintain physical activity,
- manage established metabolic risk factors,
- and treat microbiome-targeted products as specific interventions that require specific evidence.
Continue Learning
Selected Scientific References
- Singh A, et al. Role of gut microbiota in the pathogenesis of metabolic syndrome: an updated comprehensive review from mechanisms to clinical implications. 2025.
- Nature Reviews Endocrinology. Gut microbial metabolites protect against obesity. 2025.
- Depommier C, et al. Supplementation with Akkermansia muciniphila in overweight and obese human volunteers. Nature Medicine. 2019.
- Mount S, et al. Pasteurized Akkermansia muciniphila MucT for weight loss maintenance in people with overweight and obesity. Nature Medicine. 2026.
Educational Disclaimer
This article is for general education only. Microbiome research should not replace established screening or medical management of metabolic conditions.